- Exchange: NASDAQ CM
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Idera Pharmaceuticals Inc+ Add to Watchlist
IDRA:US0.6950 USD 0.0050 0.72%
As of 20:10:00 ET on 05/23/2013.
Company Profile for Idera Pharmaceuticals Inc (IDRA)
Idera Pharmaceuticals, Inc. is a biotechnology company. The Company develops therapeutics that modulate the immune response through Toll-like receptors. Idera is working on therapeutics for oncology, asthma/allergy, and infectious diseases.
Idera Pharmaceuticals Inc
Key Executives for Idera Pharmaceuticals Inc (IDRA)
|Sudhir AgrawalChairman/President/CEO||Louis J Arcudi IIISenior VP/CFO/Treasurer/Secy|
|Robert D ArbeitVP:Clinical Development||Timothy M SullivanVP:Dev Programs & Alliance|